Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era

Detalles Bibliográficos
Autores principales: Schreiber, Stefan, Ben-Horin, Shomron, Alten, Rieke, Westhovens, René, Peyrin-Biroulet, Laurent, Danese, Silvio, Hibi, Toshifumi, Takeuchi, Ken, Magro, Fernando, An, Yoorim, Kim, Dong-Hyeon, Yoon, SangWook, Reinisch, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918596/
https://www.ncbi.nlm.nih.gov/pubmed/35287234
http://dx.doi.org/10.1007/s12325-022-02082-9
Descripción
Sumario:

Ejemplares similares